Aims of the AMSP Project
The aim of the AMSP project is to improve drug safety in the treatment of psychiatric patients. Participating hospitals continuously document serious adverse drug reactions (ADRs) currently mainly among psychiatric inpatients.
After documentation, ADR cases are further discussed in ADR case conferences paying special attention to possible risk factors. In doing so, AMSP aims to improve treating physicians' knowledge of ADRs.
Lectures and publications of individual ADR cases, case series and statistical evaluations of the collected ADR data make AMSP’s findings about ADRs and potential risk factors transparent to others physicians.
AMSP is designed to have a “signal and alarm function” in the field of psychopharmacotherapy for the occurrence of clinically significant or novel ADRs.
Further, AMP aims to provide the data required to estimate the costs arising from ADRs.
